HyperSperm

DEVICE4 trials

Sponsors

Fecundis S.A., Fecundis Lab SL

Conditions

AsthenozoospermiaICSIIVF OutcomesInfertilityInfertility (IVF Patients)Male InfertilityOligozoospermiaReproductive Issues

Unknown Phase

Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients

CompletedNCT05680363

Fecundis S.A.Infertility

Start: 2023-05-01End: 2025-12-18Updated: 2026-01-08

Efficacy and Safety of a New Sperm Capacitation Method

RecruitingNCT06742437

Fecundis Lab SLAsthenozoospermia, Male Infertility, Oligozoospermia +2

Start: 2025-01-14End: 2026-09-01Target: 300Updated: 2026-09-01

Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential

RecruitingNCT07456397

Fecundis Lab SLICSI, Infertility (IVF Patients), IVF Outcomes +2

Start: 2026-03-18End: 2028-02-01Target: 500Updated: 2026-06-12

Safety Evaluation of the HyperSperm Sperm Preparation Procedure for In Vitro Fertilization

Not yet recruitingNCT07478549

Fecundis Lab SLInfertility

Start: 2026-12-01End: 2028-05-01Target: 202Updated: 2026-06-26

Related Papers

A multicenter, prospective sibling oocyte study revealed that HyperSperm<sup>™</sup> improves the number and quality of embryos in patients undergoing in vitro fertilization.

2026-06-02